Atlas Trials

Chidamide Combines With VP-16 and Methylprednisolone in the Treatment of HLH

Clinical trial NCT05137522 · UNKNOWN

Trial details

NCT number
NCT05137522
Sponsor
Beijing Friendship Hospital
Status
UNKNOWN
Phase
Not Applicable
Study type
INTERVENTIONAL
ChidamideHemophagocytic Lymphohistiocytosis
Start date
2021-07-01
Primary completion
2023-07-01
Enrollment
20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.